Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant.

Authors:
Abraham RS; Marshall JM; Kuehn HS; Rueda CM; Gibbs A and 14 more

Journal:
J Allergy Clin Immunol

Publication Year: 2020

DOI:
10.1016/j.jaci.2020.09.020

PMCID:
PMC7525247

PMID:
33007327

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Allergy Clin Immunol

Abbreviation: J Allergy Clin Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Autoimmunity and immunodeficiency associated with monoallelic LIG4 mutations via haploinsufficiency.
Jauch AJ; Bignucolo O; Seki S and 34 more (2023) - Transparency Score: 3/6
Development of mouse models with restricted HLA-B∗57:01 presentation for the study of flucloxacilli…
Ananthula S; Krishnaveni Sivakumar K; Cardone M and 6 more (2023) - Transparency Score: 3/6
Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inf…
LeSuer WE; Kienzl M; Ochkur SI and 7 more (2023) - Transparency Score: 4/6
Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and m…
Bucciol G; COVID Human Genetic Effort; Meyts I. (2023) - Transparency Score: 3/6
Phospholipid remodeling and its derivatives are associated with COVID-19 severity.
Wei J; Liu X; Xiao W and 13 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest."

Evidence found in paper:

"This study was funded by the Department of Pathology and Department of Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025